StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) shareholders

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.30−0.01 (-3.80%)

Close on Nov 17, 2026Market cap $25.51MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
93M of 86M shares
Institutional holders
189
25 new, 23 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
2 buys · 10 sales
Net sold $1.94M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
JANUS HENDERSON GROUP Ltd.9,366,33210.90%13G (passive)Aug 31, 2026
Kevin Tang
Joint filing with Tang Capital Management, LLC (9.60%)
8,250,2009.60%13G (passive)Oct 20, 2026
Cormorant Asset Management, LP
Joint filing with Bihua Chen (8.35%)
7,000,0008.35%13G (passive) amendmentJun 30, 2026
Voting Shares Irrevocable Trust
Joint filing with Federated Hermes, Inc. (8.04%), Thomas R. Donahue (8.04%) and 2 more
6,934,4148.04%13G (passive) amendmentSep 30, 2026
BlackRock, Inc.6,430,4777.70%13G (passive) amendmentJun 30, 2026
Phillip Gross
Joint filing with Adage Capital Management, L.P. (8.42%), Robert Atchinson (8.42%)
5,750,0008.42%13G (passive) amendmentDec 31, 2024
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (5.71%), Phillip Gross (5.71%)
4,790,7925.71%13G (passive)Jun 30, 2026
Aaron Cowen
Joint filing with Suvretta Capital Management, LLC (9.99%), Averill Master Fund, Ltd. (9.40%)
4,774,3899.99%13G (passive) amendmentDec 31, 2023
Robert Atchinson
Joint filing with Adage Capital Management, L.P. (5.68%), Phillip Gross (5.68%)
4,700,0005.68%13G (passive) amendmentDec 31, 2025
J. Christopher Donahue
Joint filing with Federated Hermes, Inc. (6.68%), Voting Shares Irrevocable Trust (6.68%) and 2 more
4,599,4506.68%13G (passive) amendmentJun 30, 2025
Adage Capital Partners, L.P.
Joint filing with Adage Capital Partners GP, L.L.C. (9.15%), Adage Capital Management, L.P. (9.15%) and 2 more
4,466,4209.15%13G (passive) amendmentDec 31, 2023
Robert Egen Atkinson
Joint filing with Commodore Capital LP (5.10%), Commodore Capital Master LP (5.10%) and 1 more
4,250,0005.10%13G (passive)May 27, 2026
Paradigm BioCapital Advisors LP
Joint filing with Paradigm BioCapital Advisors GP LLC (5.10%), Senai Asefaw, M.D. (5.10%)
4,192,2615.10%13G (passive)Feb 17, 2026
Franklin Resources, Inc.
Joint filing with Franklin Advisers, Inc. (6.00%)
4,137,5676.10%13G (passive) amendmentDec 31, 2024
Martin P. Sutter
Joint filing with Essex Woodlands Fund IX-GP, L.P. (5.00%), Essex Woodlands IX, LLC (5.00%) and 4 more
2,337,7865.00%13D (active) amendmentDec 4, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of EYPTValueChange% of portfolio
Suvretta Capital Management, LLC8,296,3759.62%$118.64M–2.17%
BlackRock, Inc.7,463,1978.66%$106.72M+285,8600.00%
Cormorant Asset Management, LP7,000,0008.12%$100.10M−1,265,0005.13%
Federated Hermes, Inc.5,681,0526.59%$81.24M+11,4630.12%
Adage Capital Partners Gp, L.L.C.4,827,7925.60%$69.04M+1,527,7920.10%
Franklin Resources Inc4,807,0785.58%$68.74M−241,5200.01%
Commodore Capital LP4,600,0005.34%$65.78M+1,775,0003.92%
Jupiter Topco LLC3,770,3814.37%$53.90MNew0.02%
Vanguard Capital Management LLC3,630,2524.21%$51.91M+70,6830.00%
Paradigm Biocapital Advisors LP2,890,3973.35%$41.33M−252,0400.77%
State Street Corp2,357,5452.73%$33.71M+260,3430.00%
Geode Capital Management, LLC2,062,3902.39%$29.50M+78,7250.00%
abrdn plc2,008,8022.33%$28.73M+270,4240.04%
Citadel Advisors LLC1,977,6102.29%$28.28M+71,7350.00%
Balyasny Asset Management L.P.1,812,3582.10%$25.92M+373,6210.03%
Parkman Healthcare Partners LLC1,288,1631.49%$18.42M−66,6371.89%
Eventide Asset Management, LLC1,245,5831.44%$17.81M–0.24%
Two Sigma Investments, LP1,181,1431.37%$16.89M+750,8280.01%
Essex Woodlands Management, Inc.1,084,8571.26%$15.51M–6.10%
Orbimed Advisors LLC1,069,1471.24%$15.29M–0.28%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202618993M100.0%25 / 6560 / 2313M7M
Q1 202618990M100.0%47 / 7440 / 2223M11M
Q4 202516684M97.0%33 / 7036 / 1622M8M
Q3 202515170M81.1%27 / 4248 / 189M8M
Q2 202514269M80.2%22 / 5037 / 305M10M
Q1 202515174M86.0%25 / 5745 / 185M5M
Q4 202414574M86.3%29 / 6725 / 2122M6M
Q3 202413859M68.3%21 / 4749 / 3413M9M
Q2 202415259M68.2%26 / 6346 / 3612M11M
Q1 202416358M67.2%56 / 5935 / 3114M7M
Q4 202313852M59.8%56 / 4129 / 1525M7M
Q3 20239834M39.1%24 / 3419 / 85M3M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

163 funds held EYPT in Q2 2026, 41% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of EYPTValue% of fundAs of
Federated Hermes Kaufmann Fund2,771,4873.21%$33.95M0.69%Jul 31, 2026
Vanguard Total Stock Market Index Fund2,643,8603.07%$37.81M0.00%Jun 30, 2026
iShares Russell 2000 ETF2,021,1282.34%$28.90M0.03%Jun 30, 2026
Federated Hermes Kaufmann Small Cap Fund1,982,0002.30%$24.28M0.85%Jul 31, 2026
Eventide Healthcare & Life Sciences Fund1,245,5831.44%$17.81M1.00%Jun 30, 2026
Franklin Biotechnology Discovery Fund1,123,4951.30%$13.76M1.19%Jul 31, 2026
Franklin Small Cap Growth Fund1,084,4941.26%$13.29M0.54%Jul 31, 2026
Vanguard Extended Market Index Fund895,9121.04%$12.81M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund846,5340.98%$10.37M0.03%Jul 31, 2026
iShares Russell 2000 Growth ETF607,1080.70%$8.68M0.06%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF530,2320.62%$7.58M1.77%Jun 30, 2026
Columbia Small Cap Growth Fund442,3480.51%$6.01M0.16%May 31, 2026
Fidelity Extended Market Index Fund403,1460.47%$5.47M0.01%May 31, 2026
Federated Hermes MDT Small Cap Core Fund399,7950.46%$4.90M0.22%Jul 31, 2026
Vanguard Russell 2000 Index Fund398,3380.46%$5.41M0.03%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jay S. DukerPresident and CEO, Director187,0250.22%Jul 14, 2026
George ElstonChief Financial Officer122,4700.14%Aug 24, 2026
Ramiro RibeiroChief Medical Officer4,8750.01%Jul 2, 2026
Karen L. ZaderejDirector49,1000.06%Aug 18, 2026
Nancy LurkerDirector421,2350.49%Jan 7, 2026
Reginald J. SandersDirector––Jan 6, 2026
Wendy F. DiciccoDirector9,9670.01%Jan 6, 2026
John B. LandisDirector21,4000.02%Jan 6, 2026
Stuart DutyDirector––Jan 6, 2026
Goran AndoDirector13,1500.02%Jan 6, 2026
Fred HassanDirector––Jan 6, 2026
Cormorant Asset Management, LP–8,265,0009.59%Dec 8, 2025
Bihua Chen–––Dec 8, 2025
Cormorant Global Healthcare Master Fund, LP–7,288,4798.45%Dec 8, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
George Elston
Chief Financial Officer
Aug 20, 2026Gift+64,953––64,953
George Elston
Chief Financial Officer
Aug 20, 2026Gift−64,953––32,517
George Elston
Chief Financial Officer
Aug 20, 2026Other+5,000––96,691
George Elston
Chief Financial Officer
Aug 20, 2026Other−5,000––25,000
Karen L. Zaderej
Director
Aug 18, 2026Buy+10,600$4.93$52.26K49,100
Jay S. Duker
President and CEO, Director
Jul 10, 2026Tax withholding−8,059$14.72$118.63K9,594
Jay S. Duker
President and CEO, Director
Jul 10, 2026Option exercise+16,667––17,653
Ramiro Ribeiro
Chief Medical Officer
Jun 30, 2026Option exercise+2,438$8.26$20.14K4,875
Ramiro Ribeiro
Chief Medical Officer
Jun 30, 2026Sale(10b5-1 plan)−2,437$15.00$36.56K2,438
Ramiro Ribeiro
Chief Medical Officer
Jun 30, 2026Sale(10b5-1 plan)−2,438$15.02$36.62K0
Ramiro Ribeiro
Chief Medical Officer
Jun 30, 2026Option exercise+2,437$8.26$20.13K2,437
George Elston
Chief Financial Officer
May 25, 2026Tax withholding−3,627$12.93$46.90K91,691
George Elston
Chief Financial Officer
May 25, 2026Option exercise+7,500––95,318
Ramiro Ribeiro
Chief Medical Officer
Apr 17, 2026Option exercise+2,437$8.26$20.13K2,437
Ramiro Ribeiro
Chief Medical Officer
Apr 17, 2026Sale(10b5-1 plan)−2,437$15.00$36.56K0
Jay S. Duker
President and CEO, Director
Mar 23, 2026Other+76,766$13.11$1.01M177,431
Jay S. Duker
President and CEO, Director
Mar 23, 2026Other−76,766$13.11$1.01M986
Jay S. Duker
President and CEO, Director
Mar 16, 2026Buy+1,500$13.15$19.73K100,665
Ramiro Ribeiro
Chief Medical Officer
Mar 4, 2026Sale(10b5-1 plan)−2,438$17.87$43.57K0
Ramiro Ribeiro
Chief Medical Officer
Mar 4, 2026Option exercise+2,438$8.26$20.14K2,438
George Elston
Chief Financial Officer
Mar 2, 2026Gift−5,000––87,818
George Elston
Chief Financial Officer
Mar 2, 2026Gift+5,000––30,000
Ramiro Ribeiro
Chief Medical Officer
Feb 17, 2026Option exercise+2,437$8.26$20.13K2,437
Ramiro Ribeiro
Chief Medical Officer
Feb 17, 2026Sale(10b5-1 plan)−2,437$15.00$36.56K0
George Elston
Chief Financial Officer
Jan 6, 2026Option exercise+15,285––96,339
George Elston
Chief Financial Officer
Jan 6, 2026Tax withholding−4,487$16.86$75.65K91,852
Jay S. Duker
President and CEO, Director
Jan 6, 2026Tax withholding−10,054$16.86$169.51K77,752
Jay S. Duker
President and CEO, Director
Jan 6, 2026Option exercise+20,793––87,806
Nancy Lurker
Director
Jan 6, 2026Option exercise+75,133––294,346
Ramiro Ribeiro
Chief Medical Officer
Jan 5, 2026Sale(10b5-1 plan)−42,544$17.10$727.50K0
Ramiro Ribeiro
Chief Medical Officer
Jan 5, 2026Option exercise+29,250$8.26$241.61K42,544
George Elston
Chief Financial Officer
Jan 5, 2026Option exercise+15,000––85,457
George Elston
Chief Financial Officer
Jan 5, 2026Tax withholding−4,403$17.43$76.74K81,054
Jay S. Duker
President and CEO, Director
Jan 5, 2026Tax withholding−14,505$17.43$252.82K67,013
Jay S. Duker
President and CEO, Director
Jan 5, 2026Option exercise+30,000––81,518
Nancy Lurker
Director
Jan 5, 2026Option exercise+12,666––219,213
George Elston
Chief Financial Officer
Jan 3, 2026Option exercise+19,667––76,781
George Elston
Chief Financial Officer
Jan 3, 2026Tax withholding−6,324$17.48$110.54K70,457
Ramiro Ribeiro
Chief Medical Officer
Jan 3, 2026Option exercise+19,667––19,667
Ramiro Ribeiro
Chief Medical Officer
Jan 3, 2026Tax withholding−6,373$17.48$111.40K13,294
Jay S. Duker
President and CEO, Director
Jan 3, 2026Tax withholding−23,447$17.48$409.85K51,518
Jay S. Duker
President and CEO, Director
Jan 3, 2026Option exercise+65,000––74,965
George Elston
Chief Financial Officer
Dec 19, 2025Gift+5,000––25,000
George Elston
Chief Financial Officer
Dec 19, 2025Gift−5,000––57,114
Cormorant Asset Management, LP
–
Dec 4, 2025Sale−60,000$15.70$942.00K8,265,000
Nancy Lurker
Director
Dec 4, 2025Sale(10b5-1 plan)−9,300$15.11$140.52K206,547
Nancy Lurker
Director
Nov 28, 2025Sale(10b5-1 plan)−500$14.95$7.48K215,847
Nancy Lurker
Director
Nov 26, 2025Sale(10b5-1 plan)−200$14.95$2.99K216,347
Ramiro Ribeiro
Chief Medical Officer
Nov 11, 2025Sale(10b5-1 plan)−2,722$11.61$31.60K0
George Elston
Chief Financial Officer
Sep 19, 2025Gift−20,000––62,114
George Elston
Chief Financial Officer
Sep 19, 2025Gift+20,000––20,000
Karen L. Zaderej
Director
Jul 11, 2025Option exercise+2,000––38,500
Jay S. Duker
President and CEO, Director
Jul 10, 2025Tax withholding−7,688$11.06$85.03K9,965
Jay S. Duker
President and CEO, Director
Jul 10, 2025Option exercise+16,667––17,653
Nancy Lurker
Director
Jul 10, 2025Option exercise+11,111––216,547
Jay S. Duker
President and CEO, Director
Jun 23, 2025Other−56,665$8.21$465.22K986
George Elston
Chief Financial Officer
May 25, 2025Tax withholding−2,202$5.68$12.51K80,848
George Elston
Chief Financial Officer
May 25, 2025Option exercise+7,500––83,050
Karen L. Zaderej
Director
May 19, 2025Buy+5,000$5.99$29.95K36,500
Karen L. Zaderej
Director
May 16, 2025Buy+5,000$5.81$29.05K31,500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
12.91%
11M shares short
Days to cover
1.0
At 30M shares a day
Change since last report
-48.2%
From 21M shares
Short volume, 20 days
57.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of EyePoint's stock actually held short. Settlement fails (shares not delivered on time) peaked at 17,243 shares on Aug 27, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Nancy Lurker
Officer
Jul 22, 20261,235$15.82KJul 22, 2026Stock Options
Nancy Lurker
Director
Jul 22, 20261,235$15.82KJul 22, 2026Stock Options
Nancy Lurker
Officer
Jul 21, 2026421,235$5.50MJul 21, 2026Stock Options
Ramiro Ribeiro
Officer
Apr 17, 20269,750$144.40KApr 17, 2026Exercise of Stock Options
Ramiro Ribeiro
Officer
Jan 5, 202653,792$940.28KJan 5, 2026Exercise of Stock Options
Nancy Lurker
Officer
Dec 4, 20259,300$140.48KDec 4, 2025Open Market Purchase/RSU's
Nancy Lurker
Officer
Nov 28, 2025500$7.48KNov 28, 2025Open Market Purchase/RSU's
Nancy Lurker
Officer
Nov 26, 2025200$2.99KNov 26, 2025Open Market Purchase/RSU's
Ramiro Ribeiro
Officer
Nov 12, 20252,722$30.89KNov 11, 2025Employee Stock Purchase Plan
Anthony P. Adamis
Director
Oct 23, 202467,100$673.35KOct 23, 2024Stock Option Exercise
David R. Guyer
Former Director
Oct 15, 202436,975$329.82KOct 14, 2024RSU Vesting
David R. Guyer
Director
May 14, 202471,850$897.41KMay 14, 2024RSU Vesting
David Scott Jones
Officer
Feb 2, 202410,104$288.07KFeb 2, 2024Exercise of Stock Options
David Scott Jones
Officer
Jan 24, 202434,442$857.95KJan 24, 2024Exercise of Stock Options
Nancy Lurker
Director
Jan 24, 202429,956$748.25KJan 24, 2024Open Market Purchase/RSU's

See a number that looks wrong?